Anne S Reiner

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study
    Anne S Reiner
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Clin Oncol 31:433-9. 2013
  2. pmc Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study
    Sharon N Teraoka
    Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908 0717, USA
    Breast Cancer Res 13:R114. 2011
  3. doi request reprint A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men
    Anne S Reiner
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
    Breast Cancer Res Treat 130:301-6. 2011
  4. pmc Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report
    Jonine L Bernstein
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Eur J Cancer 49:2979-85. 2013
  5. pmc Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 84:917-24. 2012
  6. pmc Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
    Cancer Causes Control 24:1605-14. 2013
  7. pmc Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 2nd Floor, New York 10065, USA
    Cancer Epidemiol Biomarkers Prev 21:2261-7. 2012
  8. pmc Body mass index and risk of second primary breast cancer: the WECARE Study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
    Breast Cancer Res Treat 131:571-80. 2012
  9. pmc Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Hum Mutat 33:158-64. 2012
  10. doi request reprint The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 251:583-91. 2010

Detail Information

Publications23

  1. pmc Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study
    Anne S Reiner
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Clin Oncol 31:433-9. 2013
    ..To fully characterize the risk of contralateral breast cancer (CBC) in patients with breast cancer with a family history who test negative for BRCA1 and BRCA2 mutations...
  2. pmc Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study
    Sharon N Teraoka
    Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908 0717, USA
    Breast Cancer Res 13:R114. 2011
    ..A subset of these SNPs, selected upon their main effects on contralateral breast cancer risk was further evaluated for interaction with treatment modalities and estrogen receptor (ER) status...
  3. doi request reprint A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men
    Anne S Reiner
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
    Breast Cancer Res Treat 130:301-6. 2011
    ..Lymphedema is a common complication affecting men with breast cancer as well as women and appropriate treatment and rehabilitation strategies need to be implemented for both genders...
  4. pmc Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report
    Jonine L Bernstein
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Eur J Cancer 49:2979-85. 2013
    ..BRCA1/BRCA2 genes help maintain genome stability and assist in DNA repair. We examined whether the risk of CBC associated with radiation treatment was higher among women with germline BRCA1/BRCA2 mutations than among non-carriers...
  5. pmc Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 84:917-24. 2012
    ..Our study examined whether reproductive and hormonal factors before, at the time of, or after radiation treatment for a first primary breast cancer modify the risk of radiation-induced second primary breast cancer...
  6. pmc Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
    Cancer Causes Control 24:1605-14. 2013
    ..The purpose of this study is to investigate the impact of germline genetic variation in genes coding for drug metabolizing enzymes, transporters, and targets on the association between chemotherapy and risk of CBC...
  7. pmc Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 2nd Floor, New York 10065, USA
    Cancer Epidemiol Biomarkers Prev 21:2261-7. 2012
    ..To explore the relationship between BMI and asynchronous contralateral breast cancer (CBC), we examined whether variants in genes related to obesity, weight, and weight change are associated with CBC risk...
  8. pmc Body mass index and risk of second primary breast cancer: the WECARE Study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
    Breast Cancer Res Treat 131:571-80. 2012
    ..Our finding of an over five-fold higher risk of CBC in a small subgroup of obese postmenopausal women with an ER-negative first primary breast cancer is based on limited numbers and requires confirmation in a larger study...
  9. pmc Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Hum Mutat 33:158-64. 2012
    ..This suggests that carriers of this haplotype may be susceptible to the DNA-damaging effects of radiation therapy associated with radiation-induced breast cancer...
  10. doi request reprint The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 251:583-91. 2010
    ..There remains variation in the use of radiation therapy (RT) in women with ductal carcinoma in situ (DCIS), despite prospective randomized trials documenting its benefit in reducing the risk of ipsilateral breast tumor recurrence (IBTR)...
  11. pmc Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Antonio Omuro
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Neuro Oncol 15:242-50. 2013
    ..In this phase II trial, we investigated the efficacy of a metronomic temozolomide schedule in the treatment of recurrent malignant gliomas (MGs)...
  12. pmc Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling
    Marinela Capanu
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Genet Epidemiol 35:389-97. 2011
    ..Hierarchical modeling is a strategy that has promise for interpreting the evidence from future association studies that involve sequencing of known or suspected cancer genes...
  13. doi request reprint Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy
    Patrick G Morris
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Leuk Lymphoma 52:1891-7. 2011
    ..51). Similarly, there were no differences in response rates or overall survival according to MTX AUC, suggesting that intra-patient dose escalation to increase MTX exposure is unnecessary when our regimen is utilized...
  14. doi request reprint Prognosis and patterns of care in elderly patients with glioma
    Fabio M Iwamoto
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 115:5534-40. 2009
    ..The current study was conducted to evaluate the patterns of care and survival of older adults with oligodendroglioma (OLI) and astrocytoma (AST) from a large population-based registry...
  15. pmc Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study
    Jonine L Bernstein
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd St Fl 3, New York, NY 10065, USA
    J Natl Cancer Inst 102:475-83. 2010
    ..We investigated whether genetic variants in ATM play a clinically significant role in radiation-induced contralateral breast cancer in women...
  16. doi request reprint Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience
    Douglas E Ney
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 116:4605-12. 2010
    ....
  17. pmc Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study
    Nancy E Thomas
    Nancy E Thomas, Pamela A Groben, Honglin Hao, and David W Ollila, University of North Carolina, Chapel Hill, NC Klaus J Busam, Irene Orlow, Anne S Reiner, and Colin B Begg, Memorial Sloan Kettering Cancer Center, New York, NY Lynn From, Women s College Hospital, Toronto, Ontario Richard P Gallagher, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada Anne Kricker and Bruce K Armstrong, The University of Sydney, Sydney, New South Wales Alison Venn, Menzies Research Institute, Tasmania, Australia Hoda Anton Culver, University of California, Irvine Stephen B Gruber, University of Southern California, Los Angeles, CA Roberto Zanetti and Stefano Rosso, Center for Cancer Prevention, Torino, Italy Terence Dwyer, International Agency for Research on Cancer, Lyon, France Peter A Kanetsky, University of Pennsylvania, Philadelphia, PA Li Luo, Susan Paine
    J Clin Oncol 31:4252-9. 2013
    ..We addressed the issue in an international population-based study of patients with single and multiple primary melanomas...
  18. doi request reprint Background parenchymal enhancement at breast MR imaging and breast cancer risk
    Valencia King
    Department of Radiology, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, 300 E 66th St, Room 715, New York, NY 10065, USA
    Radiology 260:50-60. 2011
    ..To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging...
  19. doi request reprint Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy
    Patrick G Morris
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Thorac Oncol 7:382-5. 2012
    ..A retrospective review was carried out to assess the impact of whole brain radiotherapy (WBRT), intrathecal therapy (IT), and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) on outcomes...
  20. doi request reprint Patterns of care in elderly glioblastoma patients
    Fabio M Iwamoto
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Neurol 64:628-34. 2008
    ..To evaluate the patterns of care in elderly glioblastoma (GBM) patients from a large population-based registry...
  21. doi request reprint Impact of margin assessment method on positive margin rate and total volume excised
    Tracy Ann Moo
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 21:86-92. 2014
    ..We examined our institutional experience with three different margin assessment methods used by six experienced breast surgeons...
  22. doi request reprint Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 115:1203-14. 2009
    ....
  23. pmc Vitamin D receptor polymorphisms in patients with cutaneous melanoma
    Irene Orlow
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Cancer 130:405-18. 2012
    ..The VDR may play a role in melanomagenesis...